Literature DB >> 24772054

Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.

Valentina Berti, Lisa Mosconi, Alberto Pupi.   

Abstract

Brain 18F-fluorodeoxyglucose (18F-FDG) PET allows the in vivo study of cerebral glucose metabolism, reflecting neuronal and synaptic activity. 18F-FDG-PET has been extensively used to detect metabolic alterations in several neurologic diseases compared with normal aging. However, healthy subjects have variants of 18F-FDG distribution, especially as associated with aging. This article focuses on 18F-FDG-PET findings in so-called normal brain aging, and in particular on metabolic differences occurring with aging and as a function of people’s gender. The effect of different substances, medications, and therapy procedures are discussed, as well as common artifacts.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24772054      PMCID： PMC3998066          DOI： 10.1016/j.cpet.2013.10.006

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  65 in total

1.  Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging.

Authors:  Grégoria Kalpouzos; Gaël Chételat; Jean-Claude Baron; Brigitte Landeau; Katell Mevel; Christine Godeau; Louisa Barré; Jean-Marc Constans; Fausto Viader; Francis Eustache; Béatrice Desgranges
Journal:  Neurobiol Aging       Date:  2007-07-13       Impact factor: 4.673

2.  Sex- and age-related differences in brain FDG metabolism of healthy adults: an SPM analysis.

Authors:  Te-Chun Hsieh; Wan-Yu Lin; Hueisch-Jy Ding; Shung-Shung Sun; Yu-Chin Wu; Kuo-Yang Yen; Chia-Hung Kao
Journal:  J Neuroimaging       Date:  2011-02-18       Impact factor: 2.486

Review 3.  Chemobrain: a systematic review of structural and functional neuroimaging studies.

Authors:  Marta Simó; Xavier Rifà-Ros; Antoni Rodriguez-Fornells; Jordi Bruna
Journal:  Neurosci Biobehav Rev       Date:  2013-05-06       Impact factor: 8.989

4.  Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use.

Authors:  Porche' Kirkland Henry; Kevin S Murnane; John R Votaw; Leonard L Howell
Journal:  Brain Imaging Behav       Date:  2010-12       Impact factor: 3.978

5.  Positron emission tomography study of regional cerebral metabolism in humans during isoflurane anesthesia.

Authors:  M T Alkire; R J Haier; N K Shah; C T Anderson
Journal:  Anesthesiology       Date:  1997-03       Impact factor: 7.892

6.  FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.

Authors:  Lisa Mosconi; Rachel Mistur; Remigiusz Switalski; Wai Hon Tsui; Lidia Glodzik; Yi Li; Elizabeth Pirraglia; Susan De Santi; Barry Reisberg; Thomas Wisniewski; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

7.  Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.

Authors:  In-Ju Kim; Seong-Jang Kim; Yong-Ki Kim
Journal:  Acta Radiol       Date:  2009-12       Impact factor: 1.990

8.  Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging.

Authors:  P Kochunov; A E Ramage; J L Lancaster; D A Robin; S Narayana; T Coyle; D R Royall; P Fox
Journal:  Neuroimage       Date:  2008-11-25       Impact factor: 6.556

9.  Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain".

Authors:  Jordan Sorokin; Babak Saboury; JinHyung Albert Ahn; Mateen Moghbel; Sandip Basu; Abass Alavi
Journal:  Clin Nucl Med       Date:  2014-01       Impact factor: 7.794

10.  Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain.

Authors:  Nora D Volkow; Sung Won Kim; Gene-Jack Wang; David Alexoff; Jean Logan; Lisa Muench; Colleen Shea; Frank Telang; Joanna S Fowler; Christopher Wong; Helene Benveniste; Dardo Tomasi
Journal:  Neuroimage       Date:  2012-08-28       Impact factor: 6.556
View more
  32 in total

Review 1.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

2.  Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment.

Authors:  Virgile Clergue-Duval; Frank Questel; Julien Azuar; Claire Paquet; Emmanuel Cognat; Jihed Amami; Mathieu Queneau; Alexandra Dereux; Thomas Barré; Frank Bellivier; Karim Farid; Florence Vorspan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-19       Impact factor: 9.236

3.  Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.

Authors:  Nare Torosyan; Kelsey Mason; Magnus Dahlbom; Daniel H S Silverman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-03-22       Impact factor: 9.236

Review 4.  The Role of Nutrition in Cognitive Function and Brain Ageing in the Elderly.

Authors:  Samantha L Gardener; Stephanie R Rainey-Smith
Journal:  Curr Nutr Rep       Date:  2018-09

5.  Validation of true low-dose 18F-FDG PET of the brain.

Authors:  David Fällmar; Johan Lilja; Lena Kilander; Torsten Danfors; Mark Lubberink; Elna-Marie Larsson; Jens Sörensen
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

Review 6.  Targeting Metabolism for Cancer Therapy.

Authors:  Alba Luengo; Dan Y Gui; Matthew G Vander Heiden
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

7.  Metabolic activity in subcallosal cingulate predicts response to deep brain stimulation for depression.

Authors:  Elliot C Brown; Darren L Clark; Nils D Forkert; Christine P Molnar; Zelma H T Kiss; Rajamannar Ramasubbu
Journal:  Neuropsychopharmacology       Date:  2020-06-24       Impact factor: 7.853

8.  2-18F-fluoro-2-deoxyglucose positron emission tomography in delirium.

Authors:  Lucy R Haggstrom; Julia A Nelson; Eva A Wegner; Gideon A Caplan
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-28       Impact factor: 6.200

9.  Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.

Authors:  Neelesh K Nadkarni; Dana Tudorascu; Elizabeth Campbell; Beth E Snitz; Annie D Cohen; Edye Halligan; Chester A Mathis; Howard J Aizenstein; William E Klunk
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-10-04       Impact factor: 6.053

10.  Comparison of EEG microstates with resting state fMRI and FDG-PET measures in the default mode network via simultaneously recorded trimodal (PET/MR/EEG) data.

Authors:  Ravichandran Rajkumar; Ezequiel Farrher; Jörg Mauler; Praveen Sripad; Cláudia Régio Brambilla; Elena Rota Kops; Jürgen Scheins; Jürgen Dammers; Christoph Lerche; Karl-Josef Langen; Hans Herzog; Bharat Biswal; N Jon Shah; Irene Neuner
Journal:  Hum Brain Mapp       Date:  2018-10-27       Impact factor: 5.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.